Thus, we sought to not only confirm the differential expression of RIPK2, FOXQ1, KRT23 and EPHX4 in the investigated tumor samples, but also examine whether the differential epigenetic marking of the genes was, indeed, specific for tumor cells and not from stromal contamination. The gene discussed is RIPK2; the disease is neoplasm.